logo-loader

Cello Health PLC running 'remarkably well' since going completely virtual

Published: 10:12 07 Apr 2020 EDT

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive's Andrew Scott they're coping well since first going completely remote and virtual.

''It's a lot of people, a thousand people, and we've done that successfully, all operating well and we've maintained a large number of global relationships with clients who themselves have gone virtual ... the pulse of the business is decent''.

Scott says they'll pay an interim dividend of 1p on May 22 but to maintain as much flexibility as possible during the current uncertainty they've decided to withdraw the full-year final dividend.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

2 hours, 43 minutes ago